Clariscan Alternatives Compared
| Clariscan (gadoterate meglumine) | Dotarem (gadoterate meglumine) | Gadavist (gadobutrol) |
|
|---|
| Clariscan (gadoterate meglumine) | Dotarem (gadoterate meglumine) | Gadavist (gadobutrol) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for CNS Magnetic Resonance Imaging. Clariscan may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for CNS Magnetic Resonance Imaging. Dotarem may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for CNS Magnetic Resonance Imaging, Diagnosis and Investigation, Vascular Magnetic Resonance Imaging. Gadavist may also be used for purposes not listed in this medication guide. |
Related suggestions CNS Magnetic Resonance Imaging
Popular comparisons
|
|||||||||||||||||||||||
| More about Clariscan (gadoterate meglumine) | More about Dotarem (gadoterate meglumine) | More about Gadavist (gadobutrol) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Dotarem has an average rating of 2.9 out of 10 from a total of 8 ratings on Drugs.com. 13% of reviewers reported a positive effect, while 75% reported a negative effect. |
Gadavist has an average rating of 1.3 out of 10 from a total of 8 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Clariscan side effects |
View all Dotarem side effects |
View all Gadavist side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
| Lower cost generic approved | ||||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Clariscan prices |
View all Dotarem prices |
View all Gadavist prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other gadoterate meglumine brands include: Dotarem | Other gadoterate meglumine brands include: Clariscan |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
15.1 hours |
15.1 hours |
2.13 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
|
Category C
Risk cannot be ruled out
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 40 drugs are known to interact with Clariscan:
|
A total of 40 drugs are known to interact with Dotarem:
|
A total of 31 drugs are known to interact with Gadavist:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
November 01, 2019 |
March 20, 2013 |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.